These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Biological functions of cyclooxygenase 2: control of its expression and activity]. Jacquemin C. J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321 [Abstract] [Full Text] [Related]
8. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation. Kirchner T, Argentieri DC, Barbone AG, Singer M, Steber M, Ansell J, Beers SA, Wachter MP, Wu W, Malloy E, Stewart A, Ritchie DM. J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379 [Abstract] [Full Text] [Related]
13. Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer. Pruthi RS, Derksen E, Gaston K, Wallen EM. Urology; 2004 Oct; 64(4):637-42. PubMed ID: 15491687 [No Abstract] [Full Text] [Related]
19. [Safe use of anti-inflammatory analgesics]. Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society. Duodecim; 2003 Oct; 119(22):2167-71. PubMed ID: 14702803 [No Abstract] [Full Text] [Related]
20. Cyclo-oxygenase 2 inhibitors: an important new drug classification. Kessenich CR. Pain Manag Nurs; 2001 Mar; 2(1):13-8. PubMed ID: 11705156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]